Skip to main content

Neuro-osteoarthropathy: The Charcot Foot—Pathology, Diagnosis, and Treatment

  • Chapter
  • First Online:
Management of Diabetic Foot Complications
  • 230 Accesses

Abstract

New cases of Charcot foot are uncommon, but not so uncommon that the condition does not need to be considered by non-specialists. Once the diagnosis is considered, the person with a possible acute Charcot foot should avoid any weight-bearing on the affected foot and the condition should be assessed by an expert as soon as possible. The condition results from uncontrolled inflammation within the bones, joints and soft tissues of the foot and is likely to be mediated by a number of direct and indirect consequences of neuropathy. There is no specific treatment and management relies on the provision of effective off-loading to (1) splint the affected foot in order to curtail the process of inflammation and (2) protect the affected foot from the trauma of weight-bearing while the bones and joint are vulnerable. There is no agreement on the role of surgery in the active, inflammatory, phase and it should be adopted only by experienced experts in the field. When the active phase has entered remission, there may be a place for elective surgery to correct residual deformity. The person who has had a Charcot foot should remain under long-term review because of (1) the risk of secondary ulceration resulting from residual deformity, (2) the risk of contralateral disease and (3) to address the acknowledged reduction in long-term survival.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jeffcoate WJ, Game F, Cavanagh PR. The role of pro-inflammatory cytokines in the cause of neuropathic osteoarthopathy (acute Charcot foot) in diabetes. Lancet. 2005;366:2058–61.

    Article  CAS  PubMed  Google Scholar 

  2. Game FL, Callow R, Jones GR, Edmonds ME, Jude EB, Rayman G, Jeffcoate WJ. Audit of acute Charcot’s disease in the UK: the CDUK study. Diabetologia. 2012;55:32–5.

    Article  CAS  PubMed  Google Scholar 

Further Reading

  • Jeffcoate WJ, Game FL. New theories on the cause of the Charcot foot of diabetes. In: Frykberg R, editor. The Charcot foot and ankle. Towson: DTP; 2010.

    Google Scholar 

  • Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, et al. The Charcot foot in diabetes. ADA consensus statement. Diabetes Care. 2011;34:2123–39.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jeffcoate, W.J. (2023). Neuro-osteoarthropathy: The Charcot Foot—Pathology, Diagnosis, and Treatment. In: Shearman, C.P., Chong, P. (eds) Management of Diabetic Foot Complications. Springer, Cham. https://doi.org/10.1007/978-3-031-05832-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-05832-5_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-05831-8

  • Online ISBN: 978-3-031-05832-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics